Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 clients • 4 examiners • 1 art unit • 0 of 6 (0%) have an AI response strategy ready
The Juhasz Law Firm, P.C. specializes in Biotechnology & Pharmaceuticals. The firm has handled 190 career applications. Its resolved allowance rate is 89.78 percent. This percentage reflects the success of resolved applications in reaching a grant. For a practitioner, this rate indicates the historical probability of a favorable outcome in the firm's resolved matters.
The firm currently manages 3 pending office actions. On average, the firm receives 3.14 office actions per allowance. This 3.14 office actions per allowance figure describes the typical volume of correspondence with the USPTO. The 190 career applications and 3 pending office actions provide the context for these prosecution statistics. These values outline the firm's experience and current activity level.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 6 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CLARKE, TRENT R | 3 | 42.0% | +24.0% |
| JOYCE, WILLIAM C | 1 | 69.6% | +16.0% |
| MATA, SARA M | 1 | 67.1% | +22.4% |
| GONZALEZ, JULIO CESAR | 1 | 74.6% | +14.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18835967 | POSITIONING MODULE, AND POSITIONING APPARATUS HAVING SUCH A POSITIONING MODULE | JOYCE, WILLIAM C | — |
| 18909762 | SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS | CLARKE, TRENT R | — |
| 18909731 | SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS | CLARKE, TRENT R | — |
| 18561928 | POSITIONING DEVICE AND METHOD FOR OPERATING SUCH A POSITIONING DEVICE | MATA, SARA M | — |
| 18275974 | PRELOAD DEVICE AND DRIVE DEVICE COMPRISING A PRELOAD DEVICE | GONZALEZ, JULIO CESAR | — |
| 18215498 | SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES | CLARKE, TRENT R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18835967 | POSITIONING MODULE, AND POSITIONING APPARATUS HAVING SUCH A POSITIONING MODULE | JOYCE, WILLIAM C | — |
| 18909762 | SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS | CLARKE, TRENT R | — |
| 18909731 | SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS | CLARKE, TRENT R | — |
| 18561928 | POSITIONING DEVICE AND METHOD FOR OPERATING SUCH A POSITIONING DEVICE | MATA, SARA M | — |
| 18275974 | PRELOAD DEVICE AND DRIVE DEVICE COMPRISING A PRELOAD DEVICE | GONZALEZ, JULIO CESAR | — |
| 18215498 | SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES | CLARKE, TRENT R | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Physik Instrumente | 3 |
| REVIVAL ANIMAL HEALTH, LLC | 3 |
| Art Unit | Apps |
|---|---|
| 1651 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18835967 | POSITIONING MODULE, AND POSITIONING APPARATUS HAVING SUCH A POSITIONING MODULE | Physik Instrumente (Pi) GmbH & Co. Kg | JOYCE, WILLIAM C | §102§103§112 | Non-Final OA | — | Pending | May 05, 2025 | |
| 18909762 | SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS | Revival Animal Health, LLC | CLARKE, TRENT R | 1651 | §103§112 | Final Rejection | — | Pending | Oct 08, 2024 |
| 18909731 | SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS | Revival Animal Health, LLC | CLARKE, TRENT R | 1651 | §103§112 | Final Rejection | — | Pending | Oct 08, 2024 |
| 18561928 | POSITIONING DEVICE AND METHOD FOR OPERATING SUCH A POSITIONING DEVICE | Physik Instrumente (Pi) GmbH & Co. Kg | MATA, SARA M | §103§112 | Non-Final OA | — | Pending | Nov 17, 2023 | |
| 18275974 | PRELOAD DEVICE AND DRIVE DEVICE COMPRISING A PRELOAD DEVICE | Physik Instrumente (Pi) GmbH & Co. Kg | GONZALEZ, JULIO CESAR | §103§112 | Non-Final OA | — | Pending | Aug 04, 2023 | |
| 18215498 | SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES | Revival Animal Health, LLC | CLARKE, TRENT R | 1651 | §103§112 | Final Rejection | — | Pending | Jun 28, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial